Top diabetes drugs in the United States based on revenue in 2011-2012 (in million U.S. dollars)

  Revenue in million U.S. dollars
Actos 2,736.4
Januvia 2,323.8
Lantus 2,064.7
Lantus Solostar 1,773.3
Novolog 1,073.7
Humalog 1,004.1
Levemir 947.8
Novolog Flexpen 897
Janumet 841.2
Victoza 3-Pak 587.9
Additional Information
Sign Up for Free Basic Account
Source:
Sign Up for Free Basic Account
Reading support

This statistic represents the top diabetes drugs in the United States, based on revenue between July 2011 and June 2012. In this period, diabetes drug Actos generated around 2.7 billion U.S. dollars of revenues.

You may also be interested in...
Show more
Recent Statistics
Health & Pharmaceuticals - Statistics & Facts
Health & Pharmaceuticals  - Statistics & Facts
Additional information
You can find additional information about this statistic on statista.com
http://www.statista.com/statistics/242665/revenues-of-top-diabetes-drugs-in-the-us-2011-2012/